NCT03764358

Brief Summary

Patients with diagnosed end stage renal disease and indication for chronic dialysis rely on a well-functioning access for dialysis. The KDOQI Guidelines For Vascular Access follows a "fistula first" approach for every patient, whenever possible. Thus, every patient, regardless of age, clinical state and co-morbidities an arteriovenous fistula should be preferred over a tunneled cuffed catheter (TCC). These recommendations are based on retrospective and register studies. There have been no prospective studies in this subject so far. In addition, most of the collected data refers to patients of all ages, regardless of their comorbidities and general clinical state. In this study, we address differences between two dialysis vascular access types in elderly or frail patients. We will compare TCCs with arteriovenous fistulas in the selected population consisting of elderly patients over 60 years of age or those with a Charlson Comorbidity Index \>6 independent of age. In our hypothesis TCCs will be superior to arteriovenous fistulas in this population regarding the examined end-points.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
220

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Mar 2019

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 3, 2018

Completed
2 days until next milestone

First Posted

Study publicly available on registry

December 5, 2018

Completed
3 months until next milestone

Study Start

First participant enrolled

March 6, 2019

Completed
3.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 4, 2022

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 4, 2022

Completed
Last Updated

December 5, 2018

Status Verified

December 1, 2018

Enrollment Period

3.1 years

First QC Date

December 3, 2018

Last Update Submit

December 3, 2018

Conditions

Outcome Measures

Primary Outcomes (1)

  • Composite primary end-point of any access related complication

    Loss of access, catheter related bloodstream infection/shunt infection and/or thrombosis

    From placement of vascular access through study completion, an average of 3 years.

Study Arms (2)

Arteriovenous fistula

ACTIVE COMPARATOR
Device: Arteriovenous Fistula

Tunneled Cuffed Catheter

EXPERIMENTAL
Device: Tunneled Cuffed Catheter

Interventions

Surgical implantation of an arteriovenous fistula for hemodialysis

Arteriovenous fistula

Placement of a tunneled cuffed catheter in surgical theatre

Tunneled Cuffed Catheter

Eligibility Criteria

Age18 Years - 99 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age of 60 and higher
  • CCI Score \>6 when under 60 years
  • Patients with CKD G5 A1-3 with indication for hemodialysis
  • Stable clinical condition
  • Eligibility for both arteriovenous fistula on the upper extremitiesandTCC
  • Availability for follow-up.
  • Written informed consent.

You may not qualify if:

  • Uncontrolled infection at screening and/or CRP \>5 mg/dl (normal \<0.5 mg/dl) at screening.
  • Poor general condition of health or malignancy not in remission at screening
  • Major surgery within 12 weeks before screening.
  • Pre-existent vascular access.
  • Patient not eligible for any one of the vascular access options.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Medicine III, Devision of Nephrology and Dialysis, Medical University of Vienna

Vienna, 1090, Austria

Location

MeSH Terms

Conditions

Kidney Failure, Chronic

Interventions

Arteriovenous Shunt, Surgical

Condition Hierarchy (Ancestors)

Renal Insufficiency, ChronicRenal InsufficiencyKidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Anastomosis, SurgicalSurgical Procedures, OperativeVascular GraftingVascular Surgical ProceduresCardiovascular Surgical Procedures

Study Officials

  • Guerkan Sengoelge, MD

    Medical University of Vienna, Department of Medicine III, Devision of Nephrology and Dialysis

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assoc. Prof. Priv.-Doz. Dr.

Study Record Dates

First Submitted

December 3, 2018

First Posted

December 5, 2018

Study Start

March 6, 2019

Primary Completion

April 4, 2022

Study Completion

October 4, 2022

Last Updated

December 5, 2018

Record last verified: 2018-12

Locations